Gonadal steroid regulation of mood: The lessons of premenstrual syndrome

Frontiers in Neuroendocrinology

Volumn 27, Issue 2, 2006, Pages 210-216

  Rubinow, David R ^a   Schmidt, Peter J ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Cognition; Depression; Emotion; Gonadal steroids; Hormones; Menstrual cycle; Mood; Neurocircuitry; PMS

Indexed keywords

ANTIDEPRESSANT AGENT; ESTRADIOL; ESTROGEN; LEUPRORELIN; MOOD STABILIZER; PROGESTERONE; SEX HORMONE;

BEHAVIOR DISORDER; DEPRESSION; EMOTION; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; MOOD; MOOD DISORDER; NONHUMAN; OVARY FUNCTION; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; REVIEW; SYMPTOM;

ADOLESCENT; ADULT; AFFECT; BRAIN; FEMALE; GONADAL STEROID HORMONES; HUMANS; LUTEAL PHASE; MIDDLE AGED; PREMENSTRUAL SYNDROME;

EID: 33745639449     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yfrne.2006.02.003     Document Type: Review

References (88)

1. Adams M.M., Flagg R.A., and Gore A.C. Perinatal changes in hypothalamic N-methyl-d-aspartate receptors and their relationship to gonadotropin-releasing hormone neurons. Endocrinology 140 (1999) 2288-2296
2. Adams M.M., Shah R.A., Janssen W.G.M., and Morrison J.H. Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. Proc. Natl. Acad. Sci. USA 98 (2001) 8071-8076
3. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., and Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat. Neurosci. 8 (2005) 365-371
4. Backstrom T., Sanders D., Leask R., Davidson D., Warner P., and Bancroft J. Mood, sexuality, hormones, and the menstrual cycle: II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom. Med. 45 (1983) 503-507
5. Bancroft J., Boyle H., Warner P., and Fraser H.M. The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes. Clin. Endocrinol. 27 (1987) 171-182
6. J. Beilin, J.D. Zajac, Function of the human androgen receptor varies according to CAG repeat number within the normal range, Abstr. 81st Annu. Meeting Endocr. Soc. (1999) 500.
7. Berman K.F., Schmidt P.J., Rubinow D.R., Danaceau M.A., Van Horn J.D., Esposito G., Ostrem J.L., and Weinberger D.R. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc. Natl. Acad. Sci. USA 94 (1997) 8836-8841
8. Bilang-Bleuel A., Rech J., De Carli S., Holsboer F., and Reul J.M. Forced swimming evokes a biphasic response in CREB phosphorylation in extrahypothalamic limbic and neocortical brain structures in the rat. Eur. J. Neurosci. 15 (2002) 1048-1060
9. Bloch M., Schmidt P.J., and Rubinow D.R. Premenstrual syndrome-evidence for symptom stability across cycles. Am. J. Psychiatry 154 (1997) 1741-1746
10. Brown T.J., MacLusky N.J., Shanabrough M., and Naftolin F. Comparison of age- and sex-related changes in cell nuclear estrogen-binding capacity and progestin receptor induction in the rat brain. Endocrinology 126 (1990) 2965-2972
11. Bush G., Luu P., and Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. 4 (2000) 215-222
12. Cardona-Gomez P., Perez M., Avila J., Garcia-Segura L.M., and Wandosell F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol. Cell. Neurosci. 25 (2004) 363-373
13. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 291-293
14. Cavus I., and Duman R.S. Influence of estradiol, stress, and 5-HT2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol. Psychiatry 54 (2003) 59-69
15. Chakraborty T.R., and Gore A.C. Aging-related changes in ovarian hormones, their receptors, and neuroendocrine function. Exp. Biol. Med. 229 (2004) 977-987
16. Cools R., Barker R.A., Sahakian B.J., and Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb. Cortex 11 (2001) 1136-1143
17. Cotter D., Mackay D., Landau S., Kerwin R., and Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 58 (2001) 545-553
18. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol. Psychiatry 51 (2002) 68-80
19. Diagnostic and statistical manual of mental disorders third edition-revised, American Psychiatric Association, Washington, DC, 1987.
20. J. Dreher, P. Schmidt, P. Kohn, D. Furman, R. Olsen, P. Koch, D. Rubinow, K. Berman, Menstrual cycle phase modulates the reward system in women, Abstract Viewer/Itinerary Planner, Society for Neuroscience Program No. 74.17, Washington, DC, 2005.
21. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry 48 (2000) 813-829
22. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann. N.Y. Acad. Sci. 985 (2003) 420-444
23. Drevets W.C. Neuroplasticity in mood disorders. Dial. Clin. Neurosci. 6 (2004) 199-216
24. Duman R.S. Neural plasticity: consequences of stress and actions of antidepressant treatment. Dial. Clin. Neurosci. 6 (2004) 157-169
25. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 5 (2004) 11-25
26. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., and Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
27. Garey J., Goodwillie A., Frohlich J., Morgan M., Gustafsson J.A., Smithies O., Korach K.S., Ogawa S., and Pfaff D.W. Genetic contributions to generalized arousal of brain and behavior. Proc. Natl. Acad. Sci. USA 100 (2003) 11019-11022
28. Giovannucci E., Stampfer M.J., Krithivas K., Brown M., Brufsky A., Talcott J., Hennekens C.H., and Kantoff P.W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci. USA 94 (1997) 3320-3323
29. Gotlib I.H., Joormann J., Minor K.L., and Cooney R.E. In: Canli T. (Ed). Biology of Personality and Individual Differences (2005), Guilford Press, New York, NY
30. Haldane M., and Frangou S. New insights help define the pathophysiology of bipolar affective disorder: neuroimaging and neuropathology findings. Prog. NeuroPsychopharmacol. Biol. Psychiatry 28 (2004) 943-960
31. 66 met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23 (2003) 6690-6694
32. Holland P.C., and Gallagher M. Amygdala-frontal interactions and reward expectancy. Curr. Opin. Neurobiol. 14 (2004) 148-155
33. Honda K., Sawada H., Kihara T., Urushitani M., Nakamizo T., Akaike A., and Shimohama S. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J. Neurosci. Res. 60 (2000) 321-327
34. Hruska R.E., and Silbergeld E.K. Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum. Eur. J. Pharmacol. 61 (1980) 397-400
35. Hu M., and Becker J.B. Effects of sex and estrogen on behavioral sensitization to cocaine in rats. J. Neurosci. 23 (2003) 693-699
36. Korol D.L. Role of estrogen in balancing contributions from multiple memory systems. Neurobiol. Learn. Mem. 82 (2004) 309-323
37. Krezel W., Dupont S., Krust A., Chambon P., and Chapman P.F. Increased anxiety and synaptic plasticity in estrogen receptor beta-deficient mice. Proc. Natl. Acad. Sci. USA 98 (2001) 12278-12282
38. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nature Med. 7 (2001) 541-547
39. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., and Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156 (1999) 675-682
40. McEwen B.S. Basic neurobiology of ovarian steroids: clinical implications. Dial. Clin. Neurosci. 4 (2002) 163-175
41. McEwen B.S., and Alves S.E. Estrogen actions in the central nervous system. Endocr. Rev. 20 (1999) 279-307
42. Meaney M.J., and Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dial. Clin. Neurosci. 7 (2005) 103-123
43. 3H]paroxetine binding in premenstrual dysphoria. Psychoneuroendocrinology 28 (2003) 446-458
44. Mermelstein P.G., Becker J.B., and Surmeier D.J. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J. Neurosci. 16 (1996) 595-604
45. Meyer-Lindenberg A., Kohn P.D., Kolachana B., Kippenhan S., Mclnerney-Leo A., Nussbaum R., Weinberger D.R., and Berman K.F. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat. Neurosci. 8 (2005) 594-596
46. Miranda P., Williams C.L., and Einstein G. Granule cells in aging rats are sexually dimorphic in their response to estradiol. J. Neurosci. 19 (1999) 3316-3325
47. Montague P.R., Hyman S.E., and Cohen J.D. Computational roles for dopamine in behavioural control. Nature 431 (2004) 760-767
48. Mortola J.F., Girton L., and Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J. Clin. Endocrinol. Metab. 71 (1991) 252A-252F
49. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 (1995) 7539-7547
50. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element-binding protein (CREB) in rat hippocampus. J. Neurosci. 16 (1996) 2365-2372
51. NIMH premenstrual syndrome workshop guidelines, National Institute of Mental Health, (not published), Rockville, MD, 1983.
52. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. USA 95 (1998) 13290-13295
53. Posener J.A., Wang L., Price J.L., Gado M.H., Province M.A., Miller M.I., Babb C.M., and Csernansky J.G. High-dimensional mapping of the hippocampus in depression. Am. J. Psychiatry 160 (2003) 83-89
54. Qiu J., Bosch M.A., Tobias S.C., Grandy D.K., Scanlan T.S., Ronnekleiv O.K., and Kelly M.J. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J. Neurosci. 23 (2003) 9529-9540
55. Razandi M., Pedram A., Park S.T., and Levin E.R. Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chemistry 278 (2003) 2701-2712
56. Rubinow D.R., Hoban M.C., Grover G.N., Galloway D.S., Roy-Byrne P.P., Andersen R., and Merriam G.R. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am. J. Obstet. Gynecol. 158 (1988) 5-11
57. Rubinow D.R., Roy-Byrne P.P., Hoban M.C., Gold P.W., and Post R.M. Prospective assessment of menstrually related mood disorders. Am. J. Psychiatry 141 (1984) 684-686
58. Rubinow D.R., Schmidt P.J., and Roca C.A. Estrogen-serotonin interactions: implications for affective regulation. Biol. Psychiatry 44 (1998) 839-850
59. Schmidt P.J., Grover G.N., Hoban M.C., and Rubinow D.R. State-dependent alterations in the perception of life events in menstrual-related mood disorders. Am. J. Psychiatry 147 (1990) 230-234
60. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., and Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Engl. J. Med. 338 (1998) 209-216
61. Schmidt P.J., Nieman L.K., Grover G.N., Muller K.L., Merriam G.R., and Rubinow D.R. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N. Engl. J. Med. 324 (1991) 1174-1179
62. Schnurr P.P. Measuring amount of symptom change in the diagnosis of premenstrual syndrome. Psychol. Assess. 1 (1989) 277-283
63. Schultz W. Neural coding of basic reward terms of animal learning theory, game theory, microeconomics and behavioural ecology. Curr. Opin. Neurobiol. 14 (2004) 139-147
64. Shang Y., and Brown M. Molecular determinants for the tissue specificity of SERMs. Science 295 (2002) 2465-2468
65. Shansky R.M., Glavis-Bloom C., Lerman D., McRae P., Benson C., Miller K., Cosand L., Horvath T.L., and Arnsten A.F.T. Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Mol. Psychiatry (2003) 1-8
66. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 93 (1996) 3908-3913
67. Shors T.J., and Miesegaes G. Testosterone in utero and at birth dictates how stressful experience will affect learning in adulthood. Proc. Natl. Acad. Sci. USA 99 (2002) 13955-13960
68. Siegle G.J., Steinhauer S.R., Thase M.E., Stenger V.A., and Carter C.S. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry 51 (2002) 693-707
69. Singh M., Sétáló Jr. G., Guan X., Warren M., and Toran-Allerand C.D. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci. 19 (1999) 1179-1188
70. Smith M.J., Schmidt P.J., and Rubinow D.R. Operationalizing DSM-IV criteria for PMDD: selecting symptomatic and asymptomatic cycles for research. J. Psychiatr. Res. 37 (2003) 75-83
71. Sohrabji F., Greene L.A., Miranda R.C., and Toran-Allerand C.D. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J. Neurobiol. 25 (1994) 974-988
72. Sohrabji F., Miranda R.C., and Toran-Allerand C.D. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J. Neurosci. 14 (1994) 459-471
73. Spearow J.L., Doemeny P., Sera R., Leffler R., and Barkley M. Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science 285 (1999) 1259-1261
74. Stockmeier C.A., and Rajkowska G. Cellular abnormalities in depression: evidence from postmortem brain tissue. Dial. Clin. Neurosci. 6 (2004) 185-197
75. Toran-Allerand C.D. In: Micevych P., and Hammer R.P. (Eds). Neurobiological Effects of Sex Steroid Hormones (1994), Cambridge University Press, Cambridge 391-411
76. 158 Met and beyond. Biol. Psychiatry (2005)
77. Valverde M.A., Rojas P., Amigo J., Cosmelli D., Orio P., Bahamonde M.I., Mann G.E., Vergara C., and Latorre R. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the b subunit. Science 285 (1999) 1929-1931
78. Wang-Gohrke S., Chang-Claude J., Becher H., Kieback D.G., and Runnebaum I.B. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res. 60 (2000) 2348-2350
79. Watters J.J., Campbell J.S., Cunningham M.J., Krebs E.G., and Dorsa D.M. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138 (1997) 4030-4033
80. Weaver I.C., Diorio J., Seckl J.R., Szyf M., and Meaney M.J. Early environmental regulation of hippocampal glucocorticoid receptor gene expression: characterization of intracellular mediators and potential genomic target sites. Ann. N.Y. Acad. Sci. 1024 (2004) 182-212
81. Weinberger D.R., and Goldman D. In: Watson J.D., Witkowski J.A., and Inglis J.R. (Eds). Rereading Heredity in Relation to Eugenics: Contemporary Reflections the Promise of Human Genetics (2006), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
82. Wood G.E., and Shors T.J. Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones. Proc. Natl. Acad. Sci. USA 95 (1998) 4066-4071
83. Yerkes R.M., and Dodson J.D. The relation of strength of stimulus to rapidity of habit-formation. J. Comput. Neurol. Psychol. 18 (1908) 459-482
84. Zhang J.X., Labaree D.C., Mor G., and Hochberg R.B. Estrogen to antiestrogen with a single methylene group resulting in an unusual steroidal selective estrogen receptor modulator. J. Clin. Endocrinol. Metab. 89 (2004) 3527-3535
85. Zhang L., Li B., Zhao W., Chang Y.H., Ma W., Dragan D., Barker J.L., Hu Q., and Rubinow D.R. Sex-related differences in MAPKs activation in rat astrocytes: effects of estrogen on cell death. Mol. Brain Res. 103 (2002) 1-11
86. Zhang L., Rubinow D.R., Xaing G., Li B.S., Chang Y.H., Marie D., Barker J.L., and Ma W. Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. NeuroReport 12 (2001) 1919-1923
87. Zhang L., Sukhareva M., Barker J.L., Marie D., Hao Y., Chang Y.H., Ma W., O'Shaughnessy T., and Rubinow D.R. Direct binding of estradiol enhances Slack (sequence like a calcium-activated potassium channel) channels' activity. Neuroscience 131 (2005) 275-282
88. Zhou Y., Watters J.J., and Dorsa D.M. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137 (1996) 2163-2166